Bristol Myers Squibb’s admilparant meets phase 3 IPF trial goal
Related news
- ConocoPhillips, Chevron among eight energy stocks with A+ profitability grades
-
Earnings call transcript: Can Fin Homes Q2 2027 results show growth hit by IT overhaul
- Holiday shoppers arrive early as the Amazon Prime Big Deal Days event sees strong numbers
-
European stocks inch higher as Trump’s Russia-Ukraine ceasefire softens crude
-
Goldman names 3 to benefit as high-performance NAND tackles AI’s memory wall
-
India inflation jumps to 5.54% in September, strengthening case for further rate hikes
-
Lucid Capital Markets initiates Prenetics stock with buy rating
-
BTIG initiates Quoin Pharmaceuticals stock with buy rating